[CADL] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 353.51%
YoY- 261.63%
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 31 31 31 31 31 31 31 0.00%
PBT -5,083 -8,688 -4,149 -874 1,596 -16,162 -17,080 -55.32%
Tax -15,735 -193 -4,604 -8,112 12 14 15 -
NP 10,652 -8,495 455 7,238 1,596 -16,162 -17,080 -
Tax Rate - - - - -0.75% - - -
Total Cost -10,621 8,526 -424 -7,207 -1,565 16,193 17,111 -
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 34,361.29 -27,403.23 1,467.74 23,348.39 5,148.39 -52,135.48 -55,096.77 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS 0.37 -0.29 0.02 0.25 0.07 -0.69 -0.69 -
EPS Diluted 0.37 -0.29 0.02 0.25 0.07 -0.69 -0.69 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.